PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Mesalazine (Systemic)
Presentation Product Chemical substance Chapter Items dispensed
Mesalazine 500mg/5ml oral liquid
0105010B0AAAVAV
Mesalazine Mesalazine (Systemic) Gastro-Intestinal System 4
Mesalazine 250mg suppositories
0105010B0AAAGAG
Mesalazine Mesalazine (Systemic) Gastro-Intestinal System 3
Mesren MR 400mg gastro-resistant tablets
0105010B0BGABAA
Mesren Mesalazine (Systemic) Gastro-Intestinal System 1
Asacol 1g/application foam enema
0105010B0BBAEAK
Asacol Mesalazine (Systemic) Gastro-Intestinal System No data available
Asacol 250mg suppositories
0105010B0BBADAG
Asacol Mesalazine (Systemic) Gastro-Intestinal System No data available
Ipocol 400mg gastro-resistant tablets
0105010B0BFAAAA
Ipocol Mesalazine (Systemic) Gastro-Intestinal System No data available
Mesalazine 300mg/5ml oral suspension
0105010B0AABBBB
Mesalazine Mesalazine (Systemic) Gastro-Intestinal System No data available
Mesalazine 400mg/5ml oral liquid
0105010B0AAAMAM
Mesalazine Mesalazine (Systemic) Gastro-Intestinal System No data available
Zyduco XL 1200mg tablets
0105010B0BLAAAR
Zyduco Mesalazine (Systemic) Gastro-Intestinal System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.